Fragile gene product, Fhit, in oxidative and replicative stress responses

Hiroshi Okumura, Hideshi Ishii, Flavia Pichiorri, Carlo M. Croce, Masaki Mori, Kay Huebner

Research output: Contribution to journalReview article

29 Citations (Scopus)

Abstract

Though the fragile histidine triad gene product, Fhit, was discovered and characterized as a tumor suppressor 13 years ago, its sequence, structure, and cellular location did not provide clues to aid discovery of its mechanisms of suppression. Recently, using chemical cross-linkers and immunoprecipitation, a Fhit protein complex was identified that includes Hsp60 and Hsp10 which may mediate Fhit stability and mitochondrial localization, where Fhit binds and stabilizes ferredoxin reductase (Fdxr); when Fdxr is overexpressed, it can lead to production of reactive oxygen species (ROS) that induce apoptosis. Cancer cells expressing endogenous or exogenous Fhit, when exposed to H2 O2, an oxidative stress, produce higher levels of apoptosis-inducing ROS than matched, Fhit-negative cells; the Fhit-negative cancer cells survive, carrying DNA damage. In addition to this mitochondrial function, Fhit-overexpression in cancer cells exposed to replicative stress-inducing agents leads to enhanced caspase 3 activation and apoptosis, due to defective Chk1 activation. Thus, damage to the fragile FHIT locus leads to reduced expression of Fhit protein, and makes a two-pronged contribution to development of preneoplastic clonal expansion: (1) absence or reduction of Fhit leads to reduced expression of Fdxr and reduced ROS-induced apoptosis; (2) cells that escape ROS- or replicative stress-induced apoptosis can carry misrepaired DNA damage. The aberrant DNA damage response checkpoint in Fhit-deficient preneoplasias and cancers may make these lesions targets for inhibitors of proteins such as Parp1 and Chk1 with important roles in checkpoint responses, as observed for BRCA1-deficient cancer cells that also exhibit DNA damage repair deficiencies.

Original languageEnglish
Pages (from-to)1145-1150
Number of pages6
JournalCancer Science
Volume100
Issue number7
DOIs
Publication statusPublished - Jun 23 2009

Fingerprint

Oxidative Stress
Ferredoxins
DNA Damage
Apoptosis
Reactive Oxygen Species
Genes
Neoplasms
Oxidoreductases
DNA Repair-Deficiency Disorders
Proteins
Cellular Structures
Immunoprecipitation
Histidine
Caspase 3

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Oncology

Cite this

Okumura, H., Ishii, H., Pichiorri, F., Croce, C. M., Mori, M., & Huebner, K. (2009). Fragile gene product, Fhit, in oxidative and replicative stress responses. Cancer Science, 100(7), 1145-1150. https://doi.org/10.1111/j.1349-7006.2009.01168.x

Fragile gene product, Fhit, in oxidative and replicative stress responses. / Okumura, Hiroshi; Ishii, Hideshi; Pichiorri, Flavia; Croce, Carlo M.; Mori, Masaki; Huebner, Kay.

In: Cancer Science, Vol. 100, No. 7, 23.06.2009, p. 1145-1150.

Research output: Contribution to journalReview article

Okumura, H, Ishii, H, Pichiorri, F, Croce, CM, Mori, M & Huebner, K 2009, 'Fragile gene product, Fhit, in oxidative and replicative stress responses', Cancer Science, vol. 100, no. 7, pp. 1145-1150. https://doi.org/10.1111/j.1349-7006.2009.01168.x
Okumura, Hiroshi ; Ishii, Hideshi ; Pichiorri, Flavia ; Croce, Carlo M. ; Mori, Masaki ; Huebner, Kay. / Fragile gene product, Fhit, in oxidative and replicative stress responses. In: Cancer Science. 2009 ; Vol. 100, No. 7. pp. 1145-1150.
@article{fab18af1679a41e89273b2af46ba5506,
title = "Fragile gene product, Fhit, in oxidative and replicative stress responses",
abstract = "Though the fragile histidine triad gene product, Fhit, was discovered and characterized as a tumor suppressor 13 years ago, its sequence, structure, and cellular location did not provide clues to aid discovery of its mechanisms of suppression. Recently, using chemical cross-linkers and immunoprecipitation, a Fhit protein complex was identified that includes Hsp60 and Hsp10 which may mediate Fhit stability and mitochondrial localization, where Fhit binds and stabilizes ferredoxin reductase (Fdxr); when Fdxr is overexpressed, it can lead to production of reactive oxygen species (ROS) that induce apoptosis. Cancer cells expressing endogenous or exogenous Fhit, when exposed to H2 O2, an oxidative stress, produce higher levels of apoptosis-inducing ROS than matched, Fhit-negative cells; the Fhit-negative cancer cells survive, carrying DNA damage. In addition to this mitochondrial function, Fhit-overexpression in cancer cells exposed to replicative stress-inducing agents leads to enhanced caspase 3 activation and apoptosis, due to defective Chk1 activation. Thus, damage to the fragile FHIT locus leads to reduced expression of Fhit protein, and makes a two-pronged contribution to development of preneoplastic clonal expansion: (1) absence or reduction of Fhit leads to reduced expression of Fdxr and reduced ROS-induced apoptosis; (2) cells that escape ROS- or replicative stress-induced apoptosis can carry misrepaired DNA damage. The aberrant DNA damage response checkpoint in Fhit-deficient preneoplasias and cancers may make these lesions targets for inhibitors of proteins such as Parp1 and Chk1 with important roles in checkpoint responses, as observed for BRCA1-deficient cancer cells that also exhibit DNA damage repair deficiencies.",
author = "Hiroshi Okumura and Hideshi Ishii and Flavia Pichiorri and Croce, {Carlo M.} and Masaki Mori and Kay Huebner",
year = "2009",
month = "6",
day = "23",
doi = "10.1111/j.1349-7006.2009.01168.x",
language = "English",
volume = "100",
pages = "1145--1150",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Fragile gene product, Fhit, in oxidative and replicative stress responses

AU - Okumura, Hiroshi

AU - Ishii, Hideshi

AU - Pichiorri, Flavia

AU - Croce, Carlo M.

AU - Mori, Masaki

AU - Huebner, Kay

PY - 2009/6/23

Y1 - 2009/6/23

N2 - Though the fragile histidine triad gene product, Fhit, was discovered and characterized as a tumor suppressor 13 years ago, its sequence, structure, and cellular location did not provide clues to aid discovery of its mechanisms of suppression. Recently, using chemical cross-linkers and immunoprecipitation, a Fhit protein complex was identified that includes Hsp60 and Hsp10 which may mediate Fhit stability and mitochondrial localization, where Fhit binds and stabilizes ferredoxin reductase (Fdxr); when Fdxr is overexpressed, it can lead to production of reactive oxygen species (ROS) that induce apoptosis. Cancer cells expressing endogenous or exogenous Fhit, when exposed to H2 O2, an oxidative stress, produce higher levels of apoptosis-inducing ROS than matched, Fhit-negative cells; the Fhit-negative cancer cells survive, carrying DNA damage. In addition to this mitochondrial function, Fhit-overexpression in cancer cells exposed to replicative stress-inducing agents leads to enhanced caspase 3 activation and apoptosis, due to defective Chk1 activation. Thus, damage to the fragile FHIT locus leads to reduced expression of Fhit protein, and makes a two-pronged contribution to development of preneoplastic clonal expansion: (1) absence or reduction of Fhit leads to reduced expression of Fdxr and reduced ROS-induced apoptosis; (2) cells that escape ROS- or replicative stress-induced apoptosis can carry misrepaired DNA damage. The aberrant DNA damage response checkpoint in Fhit-deficient preneoplasias and cancers may make these lesions targets for inhibitors of proteins such as Parp1 and Chk1 with important roles in checkpoint responses, as observed for BRCA1-deficient cancer cells that also exhibit DNA damage repair deficiencies.

AB - Though the fragile histidine triad gene product, Fhit, was discovered and characterized as a tumor suppressor 13 years ago, its sequence, structure, and cellular location did not provide clues to aid discovery of its mechanisms of suppression. Recently, using chemical cross-linkers and immunoprecipitation, a Fhit protein complex was identified that includes Hsp60 and Hsp10 which may mediate Fhit stability and mitochondrial localization, where Fhit binds and stabilizes ferredoxin reductase (Fdxr); when Fdxr is overexpressed, it can lead to production of reactive oxygen species (ROS) that induce apoptosis. Cancer cells expressing endogenous or exogenous Fhit, when exposed to H2 O2, an oxidative stress, produce higher levels of apoptosis-inducing ROS than matched, Fhit-negative cells; the Fhit-negative cancer cells survive, carrying DNA damage. In addition to this mitochondrial function, Fhit-overexpression in cancer cells exposed to replicative stress-inducing agents leads to enhanced caspase 3 activation and apoptosis, due to defective Chk1 activation. Thus, damage to the fragile FHIT locus leads to reduced expression of Fhit protein, and makes a two-pronged contribution to development of preneoplastic clonal expansion: (1) absence or reduction of Fhit leads to reduced expression of Fdxr and reduced ROS-induced apoptosis; (2) cells that escape ROS- or replicative stress-induced apoptosis can carry misrepaired DNA damage. The aberrant DNA damage response checkpoint in Fhit-deficient preneoplasias and cancers may make these lesions targets for inhibitors of proteins such as Parp1 and Chk1 with important roles in checkpoint responses, as observed for BRCA1-deficient cancer cells that also exhibit DNA damage repair deficiencies.

UR - http://www.scopus.com/inward/record.url?scp=67449101480&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67449101480&partnerID=8YFLogxK

U2 - 10.1111/j.1349-7006.2009.01168.x

DO - 10.1111/j.1349-7006.2009.01168.x

M3 - Review article

C2 - 19486340

AN - SCOPUS:67449101480

VL - 100

SP - 1145

EP - 1150

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 7

ER -